These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30218651)

  • 21. Optogenetics-Mediated Gene Therapy for Retinal Diseases.
    Tomita H; Sugano E
    Adv Exp Med Biol; 2021; 1293():535-543. PubMed ID: 33398840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New treatments of hereditary blindness].
    Bertelsen M; Rosenberg T; Larsen M
    Ugeskr Laeger; 2013 Sep; 175(36):2038-42. PubMed ID: 23992912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current approaches to vision restoration using optogenetic therapy.
    Parnami K; Bhattacharyya A
    Front Cell Neurosci; 2023; 17():1236826. PubMed ID: 37663125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.
    Garafalo AV; Cideciyan AV; Héon E; Sheplock R; Pearson A; WeiYang Yu C; Sumaroka A; Aguirre GD; Jacobson SG
    Prog Retin Eye Res; 2020 Jul; 77():100827. PubMed ID: 31899291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optogenetic Strategies for Vision Restoration.
    Lu Q; Pan ZH
    Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in treatment of retinitis pigmentosa.
    He Y; Zhang Y; Su G
    Curr Stem Cell Res Ther; 2015; 10(3):258-65. PubMed ID: 25345673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The functional characteristics of optogenetic gene therapy for vision restoration.
    Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
    Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances.
    McClements ME; Staurenghi F; MacLaren RE; Cehajic-Kapetanovic J
    Front Neurosci; 2020; 14():570909. PubMed ID: 33262683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ON-bipolar cell gene expression during retinal degeneration: Implications for optogenetic visual restoration.
    Gilhooley MJ; Hickey DG; Lindner M; Palumaa T; Hughes S; Peirson SN; MacLaren RE; Hankins MW
    Exp Eye Res; 2021 Jun; 207():108553. PubMed ID: 33811915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
    Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives.
    Dias MF; Joo K; Kemp JA; Fialho SL; da Silva Cunha A; Woo SJ; Kwon YJ
    Prog Retin Eye Res; 2018 Mar; 63():107-131. PubMed ID: 29097191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions.
    Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH
    Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for expanding the operational range of channelrhodopsin in optogenetic vision.
    Mutter M; Münch TA
    PLoS One; 2013; 8(11):e81278. PubMed ID: 24312285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial recovery of visual function in a blind patient after optogenetic therapy.
    Sahel JA; Boulanger-Scemama E; Pagot C; Arleo A; Galluppi F; Martel JN; Esposti SD; Delaux A; de Saint Aubert JB; de Montleau C; Gutman E; Audo I; Duebel J; Picaud S; Dalkara D; Blouin L; Taiel M; Roska B
    Nat Med; 2021 Jul; 27(7):1223-1229. PubMed ID: 34031601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Course of Ocular Function in PRPF31 Retinitis Pigmentosa.
    Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA
    Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinically viable approach to restoring visual function using optogenetic gene therapy.
    Yan B; Viswanathan S; Brodie SE; Deng WT; Coleman KE; Hauswirth WW; Nirenberg S
    Mol Ther Methods Clin Dev; 2023 Jun; 29():406-417. PubMed ID: 37251979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvaging ruins: reverting blind retinas into functional visual sensors.
    Mutter M; Swietek N; Münch TA
    Methods Mol Biol; 2014; 1148():149-60. PubMed ID: 24718800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optogenetic approaches to retinal prosthesis.
    Barrett JM; Berlinguer-Palmini R; Degenaar P
    Vis Neurosci; 2014 Sep; 31(4-5):345-54. PubMed ID: 25100257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.